TAM
HZNP

Todd Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Todd Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-716,331
Closed -$57.1M – 222
2022
Q2 		$57.1M Buy
716,331
+158,636
+28% +$15M 1.47% 7
2022
Q1 		$58.6M Buy
557,695
+39,969
+8% +$3.9M 1.29% 10
2021
Q4 		$55.8M Sell
517,726
-49,145
-9% -$5.36M 1.2% 12
2021
Q3 		$62.1M Buy
566,871
+138,177
+32% +$14.3M 1.42% 7
2021
Q2 		$40.1M Buy
428,694
+386,694
+921% +$35.6M 0.91% 27
2021
Q1 		$3.87M Buy
42,000
+12,200
+41% +$1.03M 0.09% 148
2020
Q4 		$2.18M Buy
+29,800
New +$2.22M 0.06% 163

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return